Guilbert Lab

Publications

Morgan, WJ; Mauger, DT; Bacharier, LB; Bauer, CS; Davis, SD; Fitzpatrick, AM; Guilbert, TW; Jackson, DJ; Kattan, M; Long, D; Paul, IM; Sheehan, WJ; Stokes, JR; Martinez, FD. Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial. The Lancet. 2026.

Dell, S; Guilbert, TW; Deschildre, A; Phipatanakul, W; Papadopoulos, NG; Murray, CS; Xia, C; Moraco, A; Shams, M; Bacharier, LB. Dupilumab outcomes in pediatric asthma by early eosinophil status: Post hoc analysis of VOYAGE/EXCURSION. Journal of Allergy and Clinical Immunology. 2026; 158(3):727-738.

Bachelier, LB; Chipps, BE; Coyne, KS; Eudicone, JM; George, M; Gilbert, I; Guilbert, TW; Harding, G; Lanz, MJ; Lenoir, M; Mohammad, A; Murphy, KR; Winders, T; Zeiger, RS. Pediatric Asthma Impairment and Risk Questionnaire identifies children most at risk for exacerbation. Annals of Allergy, Asthma and Immunology. 2026.

Gabryszewski, SJ; Hirabayashi, K; Botdorf, M; Maltenfort, M; Forrest, CB; Guilbert, TW; Schutt, M; Morizono, H; Vazquez Garcia, G; Garza-Mayers, AC; Hernandez, JD; Anvari, S; Rao, S; Spergel, JM. Incidence of autoimmune diseases in children with atopy treated with dupilumab. Journal of Allergy and Clinical Immunology. 2026; 158(2):533-541.

Perugini, V; Quint, JK; Fleming, L; Ducharme, FM; Guilbert, TW; Kaplan, A; Larenas-Linnemann, D; Murray, CS; Papadopoulos, NG; Paton, J; Phipatanakul, W; Price, DB; Ryan, D; Szefler, SJ; Turner, S. Prevalence and Incidence of Difficult-to-Treat Asthma in Children Between 2010 and 2020: Promise and Pitfalls of Using Routinely Acquired Prescribing Data. Journal of Allergy and Clinical Immunology: In Practice. 2026.

Gaietto, K; Krupp, N; Shah, AV; Ararat, E; Averill, SH; Baxi, S; Cernelc-Kohan, M; Chambliss, JM; Keyser, HD; Federico, M; Anderson, W; Gaffin, JM; Guilbert, TW; Forno, E. Current Practices and Variations Among Pediatric Severe Asthma Programs in the United States-The North American Severe Pediatric Asthma Consortium. Pediatric Pulmonology. 2026; 61(7):e71738.

Averill, SH; Anderson, WC; Ararat, E; Baxi, S; Cernelc-Kohan, M; De Keyser, HH; Federico, M; Gaffin, JM; Geng, B; Guilbert, TW; Tam-Williams, JB; Tantisira, KG; Krupp, N; Forno, E. A60-28 Baseline Patient Characteristics in a Large Multi-center Severe Asthma Cohort: The U.S. Severe Pediatric Asthma Consortium. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_2):aamag286.044.

He, Z; So, J; Zhou, LY; Griffin, T; Averill, SH; Gaietto, KM; Ross, SE; Edwards, T; Markel, TA; Scholz, S; Celedon, JC; Mccabe, SD; Roh, H; Forno, E. B98-09 Obesity-Related Asthma: Cell Composition Differences in Adipose Tissue Based on Single-Nucleus RNA Sequencing. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.513.

Averill, SH; Unruh, R; Silva, AE; Krupp, N; Kloepfer, KM; Gaietto, KM; Owora, AH; Han, Y; Guilbert, TW; Celedon, JC; Forno, E. A60-27 Level of Activity, Airway Inflammation and Bronchodilator Response in Youth With Asthma. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.371.

Unruh, R; Averill, SH; Silva, A; Krupp, N; Kloepfer, KM; Gaietto, KM; Owora, AH; Han, Y-Y; Guilbert, TW; Celedon, JC; Forno, E. C25-13 Associations Between Airway Dysanapsis, Lung Function, Inflammatory/Atopy Markers, and Asthma Outcomes in Youth With and Without Asthma. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.543.

Unruh, R; Averill, SH; Silva, A; Krupp, N; Kloepfer, KM; Gaietto, KM; Owora, AH; Han, Y-Y; Guilbert, TW; Celedon, JC; Forno, E. C25-14 Associations Between Anthropometry, Body Composition, and Airway Dysanapsis in Youth With and Without Asthma. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.544.

Bandyopadhyay, A; Griffin, T; Pereira, KL; Joe, A; Gaietto, KM; He, Z; Mccabe, S; Guilbert, TW; Han, Y-Y; Zhou, LY; Celedon, JC; Forno, E. C25-11 Obstructive Sleep Apnea in Children With OSA and Asthma. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.541.

Silva, A; Averill, SH; Unruh, R; Krupp, N; Kloepfer, KM; Gaietto, KM; Owora, AH; Guilbert, TW; Celedon, JC; Forno, E. A60-26 Sex Differences in Symptom Control and Quality of Life in Children With Asthma. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.370.

Guilbert, TW; Jison, M; Sjö, LB; Werkström, V; Grindebacke, H; Durżyński, T; Lal, A; Grigg, J. DOMINICA protocol: A study of benralizumab for severe eosinophilic asthma in children. Pediatric Allergy and Immunology. 2026; 37(3):e70272.

Lanz, M; Mohammad, A; Chipps, B; Bacharier, L; Murphy, K; Guilbert, T; Zeiger, R; Winders, T; Lenoir, M; Gilbert, I; Eudicone, J; Ladd, MK; Harding, G; George, M. The Pediatric Asthma Impairment and Risk Questionnaire Identifies Disparities in Morbidity Between Hispanic/Latino and Non-Hispanic White Children Better Than Other Evaluations Used in Clinical Practice. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab215.

Phipatanakul, W; Guilbert, T; Gappa, M; Ross, K; Msihid, J; Gall, R; Ledanois, O; Hamelmann, E. Children With Asthma Receiving Dupilumab Had Reduced Exacerbations and Improved Asthma Control Versus Placebo, Regardless Of Asthma Duration. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab40.

Jackson, D; Noshad, S; Song, X; Chen, C; Gandhi, AB; Avella, H; Kwah, J; Ge, W; Guilbert, T. Systemic Corticosteroid Use Among Pediatric Patients With Uncontrolled Moderate-to-Severe Asthma in the United States. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab41.

Guilbert, T; Anderson, W; Song, X; Chen, C; Noshad, S; Gandhi, AB; Avella, H; Kwah, J; Ge, W; Jackson, D. Systemic Corticosteroid Use Before Biologic Initiation Among Pediatric Patients With Asthma in the United States. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab48.

Martinez, F; Mauger, D; Bacharier, LB; Bauer, CS; Davis, S; Fitzpatrick, A; Guilbert, T; Hernandez, M; Jackson, D; Kattan, M; Sheehan, W; Jeffrey, S; Teach, S; Morgan, W. Primary Prevention of Asthma: the ORBEX trial. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab414.

Bacharier, L; Papadopoulos, N; Jackson, D; Deschildre, A; Guilbert, T; Xia, C; Ledanois, O; Gall, R; Dell, S. Baseline Predictors Of Clinical Remission In Children With Uncontrolled, Moderate-To-Severe Asthma Treated With Dupilumab: A Post Hoc Analysis Of The VOYAGE Study. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab45.

Guilbert, T; Jison, M; Sjö, LB; Werkström, V; Grindebacke, H; Durżyński, T; Lal, A; Grigg, J. Benralizumab for Severe Eosinophilic Asthma in Pediatric Patients: Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 DOMINICA Study. Journal of Allergy and Clinical Immunology. 2026; 157(2):ab48.

Rose, SJ; Nakamura, A; Hossain, MM; Guilbert, TW; Ramsey, RR. Real-World Adherence to Biologic Therapy for Severe Asthma in Children. Journal of Allergy and Clinical Immunology: In Practice. 2025; 13(12):3316-3323.

Bacharier, LB; Papadopoulos, NG; Gagnon, R; Guilbert, TW; Xia, C; Ledanois, O; Soliman, M; Maspero, JF. CO41 Children With Asthma Receiving Dupilumab Plus Medium-Dose Inhaled Corticosteroids Had Improved Exacerbations, Lung Function, and Airway Inflammation Compared To Those Receiving Placebo Plus High-Dose Inhaled Corticosteroids. Value in Health. 2025; 28(12):s49.

Dell, S; Guilbert, T; Deschildre, A; Phipatanakul, W; Papadopoulos, N; Murray, C; Xia, C; Moraco, A; Shams, M; Bacharier, L. DUPILUMAB DEMONSTRATED EFFICACY IN CHILDREN WITH ASTHMA AND EARLY CHANGES IN EOSINOPHILS COUNTS. Annals of Allergy, Asthma and Immunology. 2025; 135(5):s51-s52.

Bonder, D; Coulehan, M; Suhail, A; Kitterman, E; Guilbert, T; Anderson, W. EARLY INTERVENTION FOR OPTIMIZING LUNG FUNCTION IN PEDIATRIC ASTHMA: IMPACT OF ON-DEMAND MEDICAL EDUCATION E-LEARNING. Annals of Allergy, Asthma and Immunology. 2025; 135(5):s63.

Murphy, KR; Chipps, B; Lanz, MJ; Bacharier, LB; Guilbert, TW; George, M; Mohammad, A; Winders, T; Lenoir, M; Gilbert, IA; Eudicone, JM; Coyne, KS; Harding, G; Zeiger, RS. Pediatric Asthma Impairment and Risk Questionnaire: A Control Assessment for Children Aged 5 to 11 Years. Journal of Allergy and Clinical Immunology: In Practice. 2025; 13(10):2659-2671.

Ponda, P; Guilbert, TW. Recurrent Wheezing of Little Lungs: Big Challenges in Understanding Preschool Asthma. Journal of Allergy and Clinical Immunology: In Practice. 2025; 13(10):2588-2589.

Schuler, CL; Shi, S; Zhang, Y; Hossain, MM; Guilbert, TW. Asthma Phenotype Progression in Children and Adolescents: A Single Center Experience. Pediatric Pulmonology. 2025; 60(10):e71319.

Dell, SDM; Guilbert, T; Deschildre, A; Phipatanakul, W; Papadopoulos, N; Murray, C; Xia, C; Moraco, A; Shams, M; Bacharier, LB. DUPILUMAB DECREASES SEVERE EXACERBATION RATES AND IMPROVES LUNG FUNCTION IN CHILDREN WITH TYPE 2 ASTHMA, IRRESPECTIVE OF EARLY INCREASE IN BLOOD EOSINOPHIL COUNTS. Chest. 2025; 168(4):a5859-a5863.

Devonshire, AL; Guilbert, T; Bauer, CS; Schmidt, H; Davis, S; Hernandez, M; Fitzpatrick, AM; Gaffin, JM; Kattan, M; De, A; Stokes, JR; Teach, SJ; Morgan, WJ; Martinez, FD. Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence. Journal of Allergy and Clinical Immunology: In Practice. 2025; 13(8):1952-1959.

Bacharier, LB; Maspero, JF; Papadopoulos, NG; Gagnon, R; Guilbert, TW; Xia, C; Ledanois, O; Soliman, M. Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High-Dose ICS in Children With Uncontrolled Moderate-to-Severe Type 2 Asthma. Pediatric Pulmonology. 2025; 60(7):e71197.

Lee, B; Turner, SW; Hine, J; Mcmurray, A; Roland, D; Borland, ML; Csonka, P; Grigg, J; Guilbert, TW; Jartti, T; Oommen, A; Lewis, S; Cunningham, S. Consensus outcomes between health professionals and parents for oral corticosteroids in treating preschool wheeze: a multi-national survey and nominal group technique study. Archives of Disease in Childhood. 2025; 110(7):521-527.

Kloepfer, KM; Houser, J; Anderson, WC; Ararat, E; Baxi, S; Cernelc-Kohan, M; De Keyser, H; Federico, M; Forno, E; Gaffin, JM; Simoneau, T; Tam-Williams, JB-Y; Tantisira, KG; Larkin, A. Epinephrine Prescription and Post-injection Monitoring Practices for Biologic Therapies in Pediatric Severe Asthma Clinics: A Multicenter Survey Analysis. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a2264-a2264.

Shah, AV; Gaietto, KM; Anderson, WC; Ararat, E; Baxi, S; Chambliss, J; Federico, M; Gaffin, JM; Guilbert, TW; Kaviany, P; Tantisira, KG; Forno, E; Krupp, N; Kloepfer, KM. Current Practices Among 13 Severe Pediatric Asthma Programs in the United States. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a2249-a2249.

George, M; Chipps, BE; Murphy, KR; Lanz, MJ; Bacharier, LB; Zeiger, RS; Guilbert, TW; Mohammad, A; Lenoir, M; Gilbert, IA; Eudicone, JM; Ladd, MK; Harding, G; Winders, T. Performance of the Pediatric Asthma Impairment and Risk Questionnaire (Peds-AIRQ) in Assessing Control Relative to the Pediatric Quality of Life Inventory (PedsQL) and Patient Impression of Control. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a5022-a5022.

Phipatanakul, W; Guilbert, TW; Gappa, M; Ross, KR; Msihid, J; Gall, R; Ledanois, O; Hamelmann, E. Dupilumab Reduces Exacerbations and Improves Asthma Control in Children Regardless of Asthma Duration. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a1374-a1374.

Chipps, BE; Lanz, MJ; Zeiger, RS; Bacharier, LB; Guilbert, TW; George, M; Winders, T; Mohammad, A; Lenoir, M; Gilbert, IA; Eudicone, JM; Coyne, KS; Harding, G; Murphy, KR. Performance of the Pediatric Asthma Impairment and Risk Questionnaire (Peds-AIRQ) in Assessing Control for Children With Asthma Aged 5 to 11 Years. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a1288-a1288.

Bacharier, LB; Vogelberg, C; Maspero, JF; Papadopoulos, NG; Guilbert, TW; Xia, C; Soliman, M; Ledanois, O; Rowe, PJ; Deniz, Y; Jacob-Nara, JA; Sacks, H. Dupilumab plus medium-dose inhaled corticosteroid improves outcomes compared with placebo plus high-dose inhaled corticosteroid in pediatric patients with uncontrolled asthma. Klinische Padiatrie. 2025; 237(02):s2-s2.

Bacharier, LB; Prenzel, F; Guilbert, TW; Maspero, JF; Gappa, M; Dell, S; Altincatal, A; Ledanois, O; Gall, R; Sacks, H; Jacob-Nara, JA; Deniz, Y; Rowe, PJ. Dupilumab Induces Clinical Remission in Children with Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma. Klinische Padiatrie. 2025; 237(02):s1-s2.

Bacharier, LB; Cros, P; Guilbert, TW; Maspero, JF; Gappa, M; Dell, S; Altincatal, A; Ledanois, O; Gall, R; Sacks, H; Jacob-Nara, JA; Deniz, Y; Rowe, PJ. Rémission clinique avec le dupilumab chez les enfants atteints d’asthme de type 2 non contrôlé, modéré à sévère. Perfectionnement en Pédiatrie. 2025; 8(1):84.

Chang, WC; Burkle, JW; Williams, LR; Hammonds, MK; Weheba, FA; Satish, L; Martin, LJ; Guilbert, TW; Sherenian, MG; Mersha, TB; Biagini, JM; Khurana Hershey, GK. Race-Specific and Race-Neutral Equations for Lung Function and Asthma Diagnosis in Black Children. JAMA Network Open. 2025; 8(2):e2462176.

Rosser, FJ; Han, Y-Y; Forno, E; Guilbert, TW; Bacharier, LB; Phipatanakul, W; Celedón, JC. Vitamin D Supplementation, Long-Term PM2.5 Exposure, and Severe Asthma Exacerbations in Children with Low Vitamin D: A Post Hoc Analysis of a Double-Blind, Randomized, Placebo-controlled Trial (VDKA). American Journal of Respiratory and Critical Care Medicine. 2025; 211(2):266-268.

Lanz, MJ; Chipps, BE; Zeiger, RS; Bacharier, LB; Guilbert, TW; Murphy, KR; Winders, T; Mohammad, A; Lenoir, M; Gilbert, I; Eudicone, JM; Coyne, KS; Harding, G; George, M. Pediatric Asthma Impairment and Risk Questionnaire: Rationale and development of a composite control tool. Annals of Allergy, Asthma and Immunology. 2025; 134(2):198-208.e2.

Lanz, M; Chipps, B; Zeiger, R; Bacharier, L; Guilbert, T; George, M; Winders, T; Mohammad, A; Lenoir, M; Gilbert, I; Eudicone, J; Coyne, K; Harding, G; Murphy, K. Performance Of Asthma Control Assessments in Detecting Impairment And Risk In Demographically Diverse Children Aged 5-11 Years. Journal of Allergy and Clinical Immunology. 2025; 155(2):ab105.

Sweenie, R; Guilbert, TW; Lusebrink, R; Mullen, L; George, AS; Ramsey, RR. Outcomes and Recommendations From Telehealth Asthma Clinics in Underserved Schools. Pediatric Pulmonology. 2025; 60(2):e71003.

Dell, S; Guilbert, T; Deschildre, A; Phipatanakul, W; Papadopoulos, N; Murray, C; Xia, C; Moraco, A; Shams, M; Bacharier, L. DUPILUMAB REDUCES SEVERE EXACERBATION RATES AND TOTAL IGE LEVELS IN CHILDREN WITH TYPE 2 ASTHMA, IRRESPECTIVE OF TRANSIENT INCREASE IN EOSINOPHILS. Excellence in Pediatrics Abstracts. 2025; 17.

Sweenie, R; Crosby, LE; Guilbert, TW; Plevinsky, JM; Noser, AE; Ramsey, RR. Disparities in adolescent controller medication adherence, treatment barriers, and asthma control. Pediatric Pulmonology. 2024; 59(12):3288-3297.

Bacharier, LB; Maspero, JF; Papadopoulos, N; Guilbert, T; Xia, C; Soliman, M; Ledanois, O; Rowe, PJ; Deniz, Y; Jacob-Nara, JA; Sacks, H. DUPILUMAB PLUS MEDIUM-DOSE INHALED CORTICOSTEROID IMPROVES OUTCOMES COMPARED WITH PLACEBO PLUS HIGH-DOSE INHALED CORTICOSTEROID IN PEDIATRIC PATIENTS WITH UNCONTROLLED ASTHMA. Chest. 2024; 166(4):a4806-a4808.

Guilbert, TW; Mcdowell, KM. Impulse oscillometry: Gathering speed in the assessment of preschool lung function. Journal of Allergy and Clinical Immunology. 2024; 154(1):82-83.

Lee, B; Turner, S; Borland, M; Csonka, P; Grigg, J; Guilbert, TW; Jartti, T; Oommen, A; Twynam-Perkins, J; Lewis, S; Cunningham, S. Efficacy of oral corticosteroids for acute preschool wheeze: a systematic review and individual participant data meta-analysis of randomised clinical trials. The Lancet Respiratory Medicine. 2024; 12(6):444-456.

Bacharier, LB; Guilbert, TW; Katelaris, CH; Deschildre, A; Phipatanakul, W; Liu, D; Altincatal, A; Mannent, LP; Amin, N; Laws, E; Deniz, Y; Rowe, PJ; Lederer, DJ; Hardin, M. Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study. Journal of Allergy and Clinical Immunology: In Practice. 2024; 12(4):948-959.

Bacharier, L; Guilbert, T; Custovic, A; Altincatal, A; Ledanois, O; Gall, R; Sacks, H; Jacob-Nara, J; Deniz, Y; Rowe, P. Long-term dupilumab effect on lung function in paediatric patients with uncontrolled asthma. Pneumologie. 2024; 78:s7-s7.

Wedner, HJ; Fujisawa, T; Guilbert, TW; Ikeda, M; Mehta, V; Tam, JS; Lukka, PB; Asimus, S; Durżyński, T; Johnston, J; White, WI; Shah, M; Werkström, V; Jison, ML. Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study). Pediatric Allergy and Immunology. 2024; 35(3):e14092.

Ahdoot, S; Baum, CR; Cataletto, MB; Hogan, P; Wu, CB; Bernstein, A. Climate Change and Children's Health: Building a Healthy Future for Every Child. Pediatrics. 2024; 153(3).

Bacharier, LB; Zielen, S; Guilbert, TW; Custovic, A; Altincatal, A; Ledanois, O; Gall, R; Sacks, H; Jacob-Nara, JA; Deniz, Y; Rowe, PJ. Long-term dupilumab effect on lung function in paediatric patients with uncontrolled asthma. Klinische Padiatrie. 2024; 236(02):s2-s3.

Bacharier, LB; Maspero, JF; Katelaris, CH; Fiocchi, AG; Gagnon, R; De Mir, I; Guilbert, TW; Jackson, DJ; Staudinger, HW; Laws, E; Hardin, M; Abdulai, RM; Lederer, DJ; Robinson, LB. Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension study. The Lancet Respiratory Medicine. 2024; 12(1):45-54.

Bacharier, L; Deschildre, A; Guilbert, T; Custovic, A; Altincatal, A; Ledanois, O; Gall, R; Sacks, H; Jacob-Nara, J; Deniz, Y; Rowe, P. Effet à long terme du dupilumab sur la fonction respiratoire chez des patients pédiatriques souffrant d’asthme non contrôlé Revue des Maladies Respiratoires Actualites. 2024; 16(1):185.

Guilbert, TW; Murphy, KR; Hamelmann, E; Ross, KR; Gupta, A; Fiocchi, A; Xia, C; Gall, R; Ledanois, O; Radwan, A; Jacob-Nara, JA; Rowe, PJ; Deniz, Y. Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study. Journal of Asthma and Allergy. 2024; 17:81-87.

Guilbert, TW; Tolcachier, A; Fiocchi, AG; Katelaris, CH; Phipatanakul, W; Begin, P; De Mir, I; Altincatal, A; Gall, R; Ledanois, O; Radwan, A; Jacob-Nara, JA; Deniz, Y; Rowe, PJ. Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study. Journal of Asthma and Allergy. 2024; 17:143-159.

Bacharier, LB; Guilbert, T; Gappa, M; Dell, SD; Papadopoulos, N; Deschildre, A; Custovic, A; Altincatal, A; Ledanois, O; Gall, R; Sacks, H; Jacob-Nara, JA; Deniz, Y; Rowe, PJ. LONG-TERM DUPILUMAB EFFECT ON LUNG FUNCTION IN MULTIPLE SUBGROUPS OF PEDIATRIC PATIENTS WITH UNCONTROLLED ASTHMA. Chest. 2023; 164(4):a40-a44.

Rosser, FJ; Han, Y-Y; Forno, E; Guilbert, TW; Bacharier, LB; Phipatanakul, W; Goobie, GC; Nouraie, SM; Martinez, M; Celedón, JC. Long-Term Exposure to Particulate Matter <2.5 μm and Lung Function Change in Children with Asthma Receiving Inhaled Corticosteroids. American Journal of Respiratory and Critical Care Medicine. 2023; 208(5):622-624.

Guilbert, TW; Busse, W. How Has the Biologic Revolution Improved Patient Care? Journal of Allergy and Clinical Immunology: In Practice. 2023; 11(9):2683-2685.

Ramsey, RR; Noser, A; Mcdowell, KM; Sherman, SN; Hommel, KA; Guilbert, TW. Children with uncontrolled asthma from economically disadvantaged neighborhoods: Needs assessment and the development of a school-based telehealth and electronic inhaler monitoring system. Pediatric Pulmonology. 2023; 58(8):2249-2259.

Ramsey, RR; Plevinsky, JM; Guilbert, TW; Carmody, JK; Hommel, KA. Technology-Assisted Stepped-Care to Promote Adherence in Adolescents with Asthma: A Pilot Study. Journal of Clinical Psychology in Medical Settings. 2023; 30(2):415-424.

Mohan, A; Lugogo, NL; Hanania, NA; Reddel, HK; Akuthota, P; O'byrne, PM; Guilbert, T; Papi, A; Price, D; Jenkins, CR; Yorgancioglu, A; Martinez, F; Moore, W; Sumino, K. Questions in Mild Asthma: An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 2023; 207(11):e77-e96.

Bacharier, L; Maspero, J; Katelaris, C; Fiocchi, A; Gagnon, R; De Mir, I; Guilbert, T; Jackson, D; Li, N; Akinlade, B; Hardin, M; Abdulai, R; Lederer, D; Robinson, L. Long-Term Dupilumab Treatment Effect On Safety And Clinical Efficacy In Children With Type 2 Asthma: LIBERTY ASTHMA EXCURSION. Journal of Allergy and Clinical Immunology. 2023; 151(2):ab15.

Guilbert, T; Tolcachier, A; Fiocchi, A; Katelaris, C; Phipatanakul, W; Begin, P; Altincatal, A; Gall, R; Ledanois, O; Radwan, A; Jacob-Nara, J; Deniz, Y; Rowe, P. Impact Of Exacerbation History On Dupilumab Efficacy In Children With Asthma In The VOYAGE Study. Journal of Allergy and Clinical Immunology. 2023; 151(2):ab19.

Shipp, CL; Gergen, PJ; Gern, JE; Matsui, EC; Guilbert, TW. Asthma Management in Children. Journal of Allergy and Clinical Immunology: In Practice. 2023; 11(1):9-18.

Bacharier, LB; Maspero, JF; Katelaris, CH; Fiocchi, A; Gagnon, R; De Mir-Messa, I; Guilbert, TW; Jackson, DJ; Li, N; Akinlade, B; Hardin, M; Abdulai, R; Lederer, DJ; Robinson, LB. ASSESSMENT OF THE LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN CHILDREN WITH ASTHMA (LIBERTY ASTHMA EXCURSION STUDY) Chest. 2022; 162(4):a2677-a2679.

Kaye, L; Vuong, V; Barrett, MA; Boers, E; Guilbert, T. Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma. npj Primary Care Respiratory Medicine. 2022; 32(1):31.

Gaietto, K; Han, Y-Y; Forno, E; Bacharier, LB; Phipatanakul, W; Guilbert, TW; Cabana, MD; Ross, K; Blatter, J; Acosta-Pérez, E; Durrani, S; Canino, G; Wisniewski, SR; Celedón, JC. Violence-related distress and lung function in two longitudinal studies of youth. European Respiratory Journal. 2022; 59(5).

Guilbert, TW; Biagini, JM; Ramsey, RR; Keidel, K; Curtsinger, K; Kroner, JW; Durrani, SR; Stevens, M; Pilipenko, V; Martin, LJ; Kercsmar, CM; Hommel, K; Hershey, GKK. Treatment by biomarker-informed endotype vs guideline care in children with difficult-to-treat asthma. Annals of Allergy, Asthma and Immunology. 2022; 128(5):535-543.e6.

Guilbert, TW; Israel, E. Key Issues in Pediatric and Adult Severe Asthma: Staying Grounded as Biologics Take Us to New Heights. Journal of Allergy and Clinical Immunology: In Practice. 2022; 10(2):420-421.

Rosser, FJ; Han, Y-Y; Forno, E; Bacharier, LB; Phipatanakul, W; Guilbert, TW; Cabana, MD; Ross, K; Blatter, J; Durrani, S; Luther, J; Wisniewski, SR; Celedón, JC. Effect of vitamin D supplementation on total and allergen-specific IgE in children with asthma and low vitamin D levels. Journal of Allergy and Clinical Immunology. 2022; 149(1):440-444.e2.